Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Advanced MRI techniques, motion-correction and T2*-relaxometry, may provide information regarding functional properties of pulmonary tissue. We assessed whether lung volumes and pulmonary T2* values in fetuses with congenital diaphragmatic hernia (CDH) were lower than controls and differed between survivors and non-survivors.

Methods: Women with uncomplicated pregnancies (controls) and those with a CDH had a fetal MRI on a 1.5 T imaging system encompassing T2 single shot fast spin echo sequences and gradient echo single shot echo planar sequences providing T2* data. Motion-correction was performed using slice-to-volume reconstruction, T2* maps were generated using in-house pipelines. Lungs were segmented separately using a pre-trained 3D-deep-learning pipeline.

Results: Datasets from 33 controls and 12 CDH fetuses were analysed. The mean ± SD gestation at scan was 28.3 ± 4.3 for controls and 27.6 ± 4.9 weeks for CDH cases. CDH lung volumes were lower than controls in both non-survivors and survivors for both lungs combined (5.76 ± 3.59 [cc], mean difference = 15.97, 95% CI: -24.51--12.9, p < 0.001 and 5.73 ± 2.96 [cc], mean difference = 16, 95% CI: 1.91-11.53, p = 0.008) and for the ipsilateral lung (1.93 ± 2.09 [cc], mean difference = 19.8, 95% CI: -28.48--16.45, p < 0.001 1.58 ± 1.18 [cc], mean difference=20.15, 95% CI: 5.96-15.97, p < 0.001). Mean pulmonary T2* values were lower in non-survivors in both lungs, the ipsilateral and contralateral lungs compared with the control group (81.83 ± 26.21 ms, mean difference = 31.13, 95% CI: -58.14--10.32, p = 0.006; 81.05 ± 26.84 ms, mean difference = 31.91, 95% CI: -59.02--10.82, p = 0.006; 82.62 ± 36.31 ms, mean difference = 30.34, 95% CI: -58.84--8.25, p = 0.011) but no difference was observed between controls and CDH cases that survived.

Conclusions: Mean pulmonary T2* values were lower in CDH fetuses compared to controls and CDH cases who died compared to survivors. Mean pulmonary T2* values may have a prognostic function in CDH fetuses.

Impact: This study provides original motion-corrected assessment of the morphologic and functional properties of the ipsilateral and contralateral fetal lungs in the context of CDH. Mean pulmonary T2* values were lower in CDH fetuses compared to controls and in cases who died compared to survivors. Mean pulmonary T2* values may have a role in prognostication. Reduction in pulmonary T2* values in CDH fetuses suggests altered pulmonary development, contributing new insights into antenatal assessment.

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41390-025-04091-0DOI Listing

Publication Analysis

Top Keywords

pulmonary t2*
8
fetuses congenital
8
congenital diaphragmatic
8
diaphragmatic hernia
8
lung volumes
8
lower controls
8
controls cdh
8
single shot
8
cdh
5
controls
5

Similar Publications

Unlabelled: Leptomeningeal metastasis (LM) is a severe complication of solid malignancies, including lung adenocarcinoma, characterized by poor prognosis and diagnostic challenges. This study assesses whether curvilinear peri-brainstem hyperintense signals on MRI are a characteristic feature of LM in lung adenocarcinoma patients.

Methods: This retrospective study analyzed data from multiple centers, encompassing lung adenocarcinoma patients with peri-brainstem curvilinear hyperintense signals on MRI between January 2016 and March 2022.

View Article and Find Full Text PDF

Microenvironment-Driven Mast Cell Plasticity: Insights From Cytokine-Activated Gene Signatures in Skin and Respiratory Diseases.

Allergy

September 2025

Department of Musculoskeletal and Dermatological Sciences, Faculty of Biology, Medicine and Health, Lydia Becker Institute of Immunology and Inflammation, The University of Manchester, Manchester, UK.

Mast cells (MCs) rapidly adapt to the microenvironment due to the plethora of cytokine receptors expressed. Understanding microenvironment-primed immune responses is essential to elucidate the phenotypic/functional changes MCs undergo, and thus understand their contribution to diseases and predict the most effective therapeutic strategies. We exposed primary human MCs to cytokines mimicking a T1/pro-inflammatory (IFNγ), T2/allergic (IL-4 + IL-13), alarmin-rich (IL-33) and pro-fibrotic/pro-tolerogenic (TGFβ) microenvironment.

View Article and Find Full Text PDF

Importance: Patients with advanced cancer frequently receive broad-spectrum antibiotics, but changing use patterns across the end-of-life trajectory remain poorly understood.

Objective: To describe the patterns of broad-spectrum antibiotic use across defined end-of-life intervals in patients with advanced cancer.

Design, Setting, And Participants: This nationwide, population-based, retrospective cohort study used data from the South Korean National Health Insurance Service database to examine broad-spectrum antibiotic use among patients with advanced cancer who died between July 1, 2002, and December 31, 2021.

View Article and Find Full Text PDF

Assessment of Small Airways Function in Eosinophilic Preserved Ratio Impaired Spirometry.

Pulm Ther

September 2025

Department of Pulmonary Function Test, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, 200433, China.

Introduction: Preserved ratio impaired spirometry (PRISm) is an important phenotype of pulmonary function in clinical and public health practice. It is possible for some patients to have chronic obstructive pulmonary disease (COPD) at an early stage. At present there is little research on the association of PRISm with type 2 (T2) inflammation biomarkers.

View Article and Find Full Text PDF

Observational analysis of biological remission as a treatment target for severe asthma: UK severe asthma registry.

J Allergy Clin Immunol Pract

September 2025

Wellcome Wolfson Institute for Experimental Medicine, Queen's University Belfast, UK; Belfast Health and Social Care Trust, Belfast, UK.

Background: The aim of biologic therapies in severe asthma is inhibition of T2 inflammatory pathways.

Objective: We hypothesized that patients who achieve complete suppression of IL-5 & IL4/IL13 pathways with biologic therapy (FeNO <20ppb & blood eosinophil count (BEC) <0.15x10ˆ9, 'biological remission') would have better outcomes than patients with incomplete suppression of T2 biology.

View Article and Find Full Text PDF